MTAC
Live / Applied — First extension granted (statement of use) (as of 13 Jan 2026)
What this means for you
Not registered yet, but its 27 Feb 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97813153
- Mark type
- Stylized text
- Filed
- 27 Feb 2023
- Published for opposition
- 20 May 2025
- Attorney of record
- Brent R. Bellows
Goods and services
- Class 042 — Scientific and technological services: Research and development in the field of pharmaceutical preparations that bind to mannose 6-phosphate (M6P) receptors
Owner
- Avilar Therapeutics, Inc., Waltham, MA, US
- Avilar Therapeutics, Inc., Waltham, MA, US
Prosecution history
- 14 Jan 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Jan 2026 — SOU EXTENSION 1 GRANTED
- 13 Jan 2026 — SOU EXTENSION 1 FILED
- 13 Jan 2026 — SOU TEAS EXTENSION RECEIVED
- 15 Jul 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 20 May 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 20 May 2025 — PUBLISHED FOR OPPOSITION
- 14 May 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 19 Apr 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 19 Apr 2025 — ALLEGED AMENDMENT TO USE WITHDRAWN
- 10 Mar 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 10 Mar 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 10 Mar 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 17 Dec 2024 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 17 Dec 2024 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED